Mark Blecher, MD Co-Chief of Wills Eye Hospital Cataract and Primary Eye Care Service comments on the recent FDA approval of an extended range intraocular lens.
The U.S. Food and Drug Administration today approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances.
